Basel, 30 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the primary results from the TSIX Study Program, which evaluated the performance of its new sixth-generation high-sensitivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback